Dalid, Jerlyn T.

HRN: 06-30-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
MUPIROCIN 2%, 15G (TUBE)
06/30/2026
07/07/2026
TOPICAL
2%
BID
S/P PLSTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: